These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4569931)

  • 1. The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B.
    Davies P; Fox RI; Polyzonis M; Allison AC; Haswell AD
    Lab Invest; 1973 Jan; 28(1):16-22. PubMed ID: 4569931
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective release of lysosomal hydrolases from phagocytic cells by cytochalasin B.
    Davies P; Allison AC; Haswell AD
    Biochem J; 1973 May; 134(1):33-41. PubMed ID: 4737379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochalasin B: effect on lysosomal enzyme release from human leukocytes.
    Zurier RB; Hoffstein S; Weissmann G
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):844-8. PubMed ID: 4351807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.
    Spilberg I; Gallacher A; Mendell B
    J Lab Clin Med; 1975 Apr; 85(4):631-6. PubMed ID: 1120930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes.
    Hoffstein S; Weissmann G
    Arthritis Rheum; 1975; 18(2):153-65. PubMed ID: 48382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of various particles and 3', 5' cyclic adenosine monophosphate on release of lysosomal enzymes by mouse macrophages.
    Welscher HD; Cruchaud A
    J Reticuloendothel Soc; 1976 Dec; 20(6):405-20. PubMed ID: 13212
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.
    Goldstein IM; Brai M; Osler AG; Weissmann G
    J Immunol; 1973 Jul; 111(1):33-7. PubMed ID: 4197335
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.
    Goldstein IM; Weissmann G
    J Immunol; 1974 Nov; 113(5):1583-8. PubMed ID: 4473046
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes.
    Elferink JG
    Biochem Pharmacol; 1979 Apr; 28(7):965-8. PubMed ID: 375938
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cytochalasin B on response of human polymorphonuclear leukocytes to zymosan.
    Skosey JL; Chow D; Damgaard E; Sorensen LB
    J Cell Biol; 1973 Apr; 57(1):237-40. PubMed ID: 4691395
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles.
    Weissmann G; Zurier RB; Spieler PJ; Goldstein IM
    J Exp Med; 1971 Sep; 134(3 Pt 2):149s-165s. PubMed ID: 5570749
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cytochalasin B on endocytosis and exocytosis.
    Davies P; Allison AC
    Front Biol; 1978; 46():143-60. PubMed ID: 352738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysotile asbestos-induced cytotoxicity and calcium-dependent exocytosis in polymorphonuclear leukocytes.
    Elferink JG
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):361-72. PubMed ID: 2554437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cytochalasin A on polymorphonuclear leukocytes activated by chemotactic peptide.
    Elferink JG; Riemersma JC
    J Reticuloendothel Soc; 1981 Feb; 29(2):163-71. PubMed ID: 6260942
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of divalent cations upon complement-mediated enzyme release from human polymorphonuclear leukocytes.
    Goldstein IM; Hoffstein ST; Weissmann G
    J Immunol; 1975 Sep; 115(3):665-70. PubMed ID: 1151072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible phagocytosis in rabbit polymorphonuclear leukocytes.
    Berlin RD; Fera JP; Pfeiffer JR
    J Clin Invest; 1979 Jun; 63(6):1137-44. PubMed ID: 109468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytic proteases and the immunologic release of lysosomal enzymes.
    Weissmann G; Zurier RB; Hoffstein S
    Am J Pathol; 1972 Sep; 68(3):539-64. PubMed ID: 4340975
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing the release of procoagulant-tissue factor activity from leukocytes.
    Muhlfelder TW; Khan I; Niemetz J
    J Lab Clin Med; 1978 Jul; 92(1):65-72. PubMed ID: 659965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of polymorphonuclear leukocytes to immune complexes in vitro.
    Hawkins D; Peeters S
    Lab Invest; 1971 Jun; 24(6):483-91. PubMed ID: 4103850
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.
    Henson PM
    J Immunol; 1971 Dec; 107(6):1535-46. PubMed ID: 5120396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.